CEIV 2.0 Phase 2: Implementation
Project Purpose
In 2021, six years into the CEIV Pharma program, Pharma.Aero initiated the CEIV 2.0 Project to evaluate how CEIV Pharma-certified companies perceive the impact of the CEIV certification on their daily business and the value that the certification has brought. Furthermore, Pharma.Aero involved their strategic pharma shipper members in evaluating the current CEIV Pharma programme and its impact on their air supply chain requirements.
As part of Phase 1: Evaluation, the project focused on identifying the challenges, and root causes and suggested potential solutions. The methodology and the findings of Phase 1: Evaluation are available here.
Based on the identified challenges and the suggested solutions for improvement, Pharma.Aero members and project participants launched a follow-up project, CEIV 2.0 Phase 2: Implementation to further explore concrete actions to implement some of the suggested potential solutions.
Project Objective(s)
After Phase 1 of the Project, the goal is to work on 6 specific solutions highlighted by Pharma.Aero members and make some suggestion to IATA on how to implement them to enhance the IATA CEIV Pharma Program.
Project Status And Key-takeaways
Project ongoing, following the steps:
-
Work Package 1: Host and exclusive webinar for the members of both organisations (Pharma.Aero and HLA) on June 15, 2021, followed by a survey. The results of the survey and insights gathered amongst the presenters, the attendees and the project group were outlined in a White Paper. This first report examined the competitive positioning of UAV against other transportation modes, the regulatory framework for drone operations and applications of UAV in the Pharma and Humanitarian Air Cargo sector.
-
Work Package 2: Create a 360° interactive video to showcase drone lab technologies, different types of drones and drone operations. This video is now available for Pharma.Aero members only.
-
Work Package 3: Map the journey of the Covid-19 vaccines from the manufacture point in Europe to the arm of the patient in Malawi. Draft a list of recommendations on how to optimize the end-to-end transportation by shortening the supply chain and linking both traditional airfreight and drone worlds. Disseminate a theoretical proof of concept (technical report and white paper). See here the video of the Vaccines transportation from Belgium to Malawi.
PROJECT
SUPPORT AND
COLLABORATION.
- Pharma.Aero Board liaison: Brussels Airport Company
- Project leads: Dnata, Expeditors
- Project members: Pharma.Aero members and partners involved in the different Work Packages, based on their interest and expertise
- Project manager: 4Advice (external consultant)
- Project experts: MdG Consulting (external consultant)
